Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia

Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve. Various medicinal or surgical modalities have been employed in the past with variable success. Newer me...

Descripción completa

Detalles Bibliográficos
Autor principal: Verma, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806369/
https://www.ncbi.nlm.nih.gov/pubmed/24194982
http://dx.doi.org/10.1155/2013/831094
_version_ 1782288369404870656
author Verma, Gaurav
author_facet Verma, Gaurav
author_sort Verma, Gaurav
collection PubMed
description Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve. Various medicinal or surgical modalities have been employed in the past with variable success. Newer methods were tried in search of permanent cure or long-lasting pain relief. The purpose of this paper is to present the review of the literature regarding the use of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia.
format Online
Article
Text
id pubmed-3806369
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38063692013-11-05 Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia Verma, Gaurav Pain Res Treat Review Article Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve. Various medicinal or surgical modalities have been employed in the past with variable success. Newer methods were tried in search of permanent cure or long-lasting pain relief. The purpose of this paper is to present the review of the literature regarding the use of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia. Hindawi Publishing Corporation 2013 2013-10-01 /pmc/articles/PMC3806369/ /pubmed/24194982 http://dx.doi.org/10.1155/2013/831094 Text en Copyright © 2013 Gaurav Verma. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Verma, Gaurav
Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title_full Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title_fullStr Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title_full_unstemmed Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title_short Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
title_sort role of botulinum toxin type-a (btx-a) in the management of trigeminal neuralgia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806369/
https://www.ncbi.nlm.nih.gov/pubmed/24194982
http://dx.doi.org/10.1155/2013/831094
work_keys_str_mv AT vermagaurav roleofbotulinumtoxintypeabtxainthemanagementoftrigeminalneuralgia

Ejemplares similares